VRCA · Verrica Pharmaceuticals Inc.
$4.97
+0.11 (+2.26%)
At close · Aug 14
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists regarding its ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$85.38M
Shares
17.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-06-09 | 2026-06-05 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-20 | 2026-06-05 | |
| 8-K | 2026-03-11 | — | |
| 10-K | 2026-03-11 | 2025-12-31 | |
| 8-K | 2025-12-30 | 2025-12-23 | |
| 8-K | 2025-11-24 | 2025-11-23 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-14 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | 2025-08-08 | |
| 8-K | 2025-07-30 | 2025-07-24 | |
| 8-K | 2025-07-23 | 2025-07-22 | |
| 8-K | 2025-07-01 | 2025-06-27 | |
| 8-K | 2025-06-12 | 2025-06-10 | |
| 8-K | 2025-06-05 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-04-25 | 2025-04-22 | |
| DEF 14A | 2025-04-22 | 2025-06-05 | |
| 8-K | 2025-04-02 | 2025-03-31 | |
| 8-K | 2025-03-11 | — | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-02-21 | 2025-02-18 | |
| 8-K | 2025-01-30 | 2025-01-24 | |
| 8-K | 2024-12-09 | 2024-12-04 | |
| 8-K | 2024-11-21 | 2024-11-20 | |
| 8-K | 2024-11-20 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-11-04 | 2024-11-01 | |
| 8-K | 2024-10-08 | 2024-10-02 | |
| 8-K | 2024-10-01 | — | |
| 8-K | 2024-09-27 | 2024-09-23 | |
| 8-K | 2024-09-06 | 2024-08-30 | |
| 8-K | 2024-08-27 | 2024-08-21 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-14 | — | |
| 8-K | 2024-08-05 | 2024-08-02 | |
| 8-K | 2024-06-28 | 2024-06-26 | |
| 8-K | 2024-06-10 | 2024-06-06 | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 8-K | 2024-05-13 | — | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| DEF 14A | 2024-04-19 | 2024-06-06 | |
| 8-K | 2024-02-29 | — | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2024-01-08 | — |
Showing 1–50 of 124 filings
Key facts
CIK
1660334
CUSIP
92511W207
13F (30d)
42 filings
42 filers
Visit website
Investor relations